Vertex Pharmaceuticals Company

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

Connections from

Technology: P4 Medicine
Industry: Regenerative Medicine
Headquarters: Boston, Massachusetts, United States
Founded Date: 6-11
Employees Number: 1001-5000
Funding Status: IPO
Total Funding: $600.4M
Estimated Revenue: $500M to $1B
Last Funding Type: Post-IPO Equity

Visit Website
mediainfo@vrtx.com
@VertexPharma
Register and Claim Ownership